Avient (AVNT) is drawing fresh attention after recent share price moves, with the stock closing at $39.90. For investors, the latest returns across the month and past 3 months invite a closer look.
See our latest analysis for Avient.
Avient’s recent share price pullback over the past week sits against a stronger backdrop, with a 30 day share price return of 9.17% and a 90 day share price return of 28.96%. However, the 1 year total shareholder return of a 2.10% decline shows that longer term holders have seen a more mixed picture.
If this kind of move has you looking beyond a single materials name, it could be a good moment to widen your search with our 20 top founder-led companies.
With the share price near $39.90, recent returns mixed, and the stock trading at roughly a 24% discount to both analyst targets and one intrinsic estimate, is Avient a value opportunity, or is the market already pricing in future growth?
Avient’s most followed narrative points to a fair value of $48.25 against the last close at $39.90, which sets up a clear valuation gap for investors to weigh.
Ongoing footprint optimization, Lean Six Sigma initiatives, and discretionary spending controls are structurally lowering operating costs and improving productivity, leading to sustained improvements in EBITDA margins and higher free cash flow generation.
Want to see what sits behind that cash flow story? The narrative leans on steadier revenue, higher margins, and a tighter cost base to back its valuation call. The exact mix of those assumptions is where things get interesting.
Result: Fair Value of $48.25 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on demand not weakening further in consumer end markets, as well as raw material and regulatory pressures in areas like China remaining manageable.
Find out about the key risks to this Avient narrative.
Here is the tension: While one model points to Avient trading about 24% below fair value, the current P/E of 44.6x sits well above the US Chemicals industry at 23.5x, peers at 26.4x, and a fair ratio of 30.1x. That rich multiple can mean valuation risk if earnings progress stalls.
See what the numbers say about this price — find out in our valuation breakdown.
Mixed signals or a clear message, either way it is worth checking the full picture for yourself and acting while the data is fresh, starting with 3 key rewards and 4 important warning signs.
If Avient has sharpened your focus, do not stop here. Widen your watchlist with a few focused stock ideas built from clear fundamentals and returns.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com